ACYCLOVIR
- Product NDC
- 71335-1757
- 11-digit product format
- 713351757
- Labeler code
- 71335
- Product ID
- 71335-1757_45462e20-c9a7-48c1-a1b4-13a1be79a3e5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ACYCLOVIR
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA074891
- Marketing category
- ANDA
- Marketing start
- 2013-08-08
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data
- Finished product
- Yes
- Brand name base
- ACYCLOVIR
- Listing expiration
- 2026-12-31
Active Ingredients
| Ingredient | Strength |
|---|
| ACYCLOVIR | 400 mg/1 |
Harmonized Identifiers
| Field | Values |
|---|
| Unii | X4HES1O11F |
| Rxcui | 197311 |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1757-1 | 71335175701 | 35 TABLET in 1 BOTTLE (71335-1757-1) | 35 tablet | 2022-01-28 | 0000-00-00 | No | No | Current |
| 71335-1757-2 | 71335175702 | 90 TABLET in 1 BOTTLE (71335-1757-2) | 90 tablet | 2021-01-04 | 0000-00-00 | No | No | Current |